Bioventus (NASDAQ:BVS) just reported results for the first quarter of 2024.
- Bioventus reported earnings per share of 7 cents. This was above the analyst estimate for EPS of -7 cents.
- The company reported revenue of $129.46 million.
- This was 9.36% better than the analyst estimate for revenue of $118.38 million.